Save New Eucrisa as an Eczema Option After Topical Steroids

February 2017

The new Eucrisa (you-KRIS-ah, crisaborole) ointment will raise questions about how to manage eczema.

Eucrisa is the first new drug approved for eczema in over a decade. It inhibits phosphodiesterase 4...an enzyme that promotes inflammation.

Think of Eucrisa as a possible second-line med option for mild to moderate eczema...after topical corticosteroids.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote